Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Current status of alpha-1-antitrypsin replacement therapy: recommendations for the management of patients with severe hereditary deficiency. Ad Hoc Committee on Alpha-1-Antitrypsin Replacement Therapy of the Standards Committee, Canadian Thoracic Society.

Literature DB >> 1544074

Current status of alpha-1-antitrypsin replacement therapy: recommendations for the management of patients with severe hereditary deficiency. Ad Hoc Committee on Alpha-1-Antitrypsin Replacement Therapy of the Standards Committee, Canadian Thoracic Society.

Abstract

Entities: Disease Gene Species

Mesh：

Substances：
alpha 1-Antitrypsin

Year: 1992 PMID： 1544074 PMCID： PMC1488610

Source DB: PubMed Journal: CMAJ ISSN： 0820-3946 Impact factor: 8.262

× No keyword cloud information.

17 in total

Review 1. Pulmonary disease in alpha-1-antitrypsin deficiency.

Authors: G L Snider
Journal: Ann Intern Med Date: 1989-12-15 Impact factor: 25.391

Review 2. The alpha 1-antitrypsin gene and its mutations. Clinical consequences and strategies for therapy.

Authors: R G Crystal; M L Brantly; R C Hubbard; D T Curiel; D J States; M D Holmes
Journal: Chest Date: 1989-01 Impact factor: 9.410

3. Pathogenesis of emphysema. Assessment of basic science concepts through clinical investigation.

Authors: M Wewers
Journal: Chest Date: 1989-01 Impact factor: 9.410

4. Anti-neutrophil-elastase defenses of the lower respiratory tract in alpha 1-antitrypsin deficiency directly augmented with an aerosol of alpha 1-antitrypsin.

Authors: R C Hubbard; M L Brantly; S E Sellers; M E Mitchell; R G Crystal
Journal: Ann Intern Med Date: 1989-08-01 Impact factor: 25.391

5. Natural history and life expectancy in severe alpha1-antitrypsin deficiency, Pi Z.

Authors: C Larsson
Journal: Acta Med Scand Date: 1978

Review 6. Alpha-1-antitrypsin deficiency. High prevalence in the St. Louis area determined by direct population screening.

Authors: E K Silverman; J P Miletich; J A Pierce; L A Sherman; S K Endicott; G J Broze; E J Campbell
Journal: Am Rev Respir Dis Date: 1989-10

7. Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants.

Authors: T Sveger
Journal: N Engl J Med Date: 1976-06-10 Impact factor: 91.245

8. Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates.

Authors: E K Silverman; J A Pierce; M A Province; D C Rao; E J Campbell
Journal: Ann Intern Med Date: 1989-12-15 Impact factor: 25.391

9. Alveolar macrophages from patients with asbestos exposure release increased levels of leukotriene B4.

Authors: J G Garcia; D E Griffith; A B Cohen; K S Callahan
Journal: Am Rev Respir Dis Date: 1989-06

10. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.

Authors: D S Echt; P R Liebson; L B Mitchell; R W Peters; D Obias-Manno; A H Barker; D Arensberg; A Baker; L Friedman; H L Greene
Journal: N Engl J Med Date: 1991-03-21 Impact factor: 91.245

5 in total

1. Alpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guideline.

Authors: Darcy D Marciniuk; P Hernandez; M Balter; J Bourbeau; K R Chapman; G T Ford; J L Lauzon; F Maltais; D E O'Donnell; D Goodridge; C Strange; A J Cave; K Curren; S Muthuri
Journal: Can Respir J Date: 2012 Mar-Apr Impact factor: 2.409